| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01644137 |
| P698 | PubMed publication ID | 3117700 |
| P2093 | author name string | A Bauernfeind | |
| B Przyklenk | |||
| C Weisslein-Pfister | |||
| G Hörl | |||
| K Harms | |||
| R Jungwirth | |||
| R M Bertele | |||
| C Petermüller | |||
| P2860 | cites work | Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood | Q35114337 |
| A simple test system for the separation of staphylococci from micrococci | Q37361149 | ||
| Why is Pseudomonas the colonizer and why does it persist? | Q39597632 | ||
| Rational parameters for antibiotic therapy in patients with cystic fibrosis | Q39597641 | ||
| Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis | Q39714807 | ||
| Revised pyocin typing method for Pseudomonas aeruginosa | Q40218678 | ||
| Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. | Q40230334 | ||
| Pseudomonas cepacia infection in cystic fibrosis: an emerging problem | Q40829590 | ||
| Aspergillus Antibody in Patients With Cystic Fibrosis | Q45383250 | ||
| Selective media for the quantitation of bacteria in cystic fibrosis sputum. | Q54476829 | ||
| Aspergillosis and atopy in cystic fibrosis | Q66970302 | ||
| Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis | Q69898483 | ||
| Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa | Q70363290 | ||
| Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981 | Q70467117 | ||
| Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis | Q70471737 | ||
| Allergic bronchopulmonary aspergillosis in cystic fibrosis | Q71261436 | ||
| Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis | Q71645528 | ||
| [Aspergillus fumigatus infection of the lung in cystic fibrosis (author's transl)] | Q72129711 | ||
| RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS | Q76538168 | ||
| Celiac syndrome; chemotherapy in infections of the respiratory tract associated with cystic fibrosis of the pancreas; observations with penicillin and drugs of the sulfonamide group, with special reference to penicillin aerosol | Q82160244 | ||
| P433 | issue | 4 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 270-277 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | Infection | Q15710156 |
| P1476 | title | Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis | |
| P478 | volume | 15 |
| Q35946121 | Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease |
| Q41950074 | Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms |
| Q35066763 | Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. |
| Q54200267 | Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. |
| Q28741795 | Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists |
| Q45821784 | Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis |
| Q37006887 | Binding of staphylococci to mucus in vivo and in vitro |
| Q27317563 | Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis |
| Q34536205 | Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis |
| Q36981240 | Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling |
| Q43276197 | Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis |
| Q42176982 | Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. |
| Q41568678 | Epidemiological typing of Stenotrophomonas maltophilia |
| Q43082590 | Epidemiology of Staphylococcus aureus in patients with cystic fibrosis |
| Q49679927 | Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All. |
| Q46314594 | Gallstones containing bacteria are biofilms: bacterial slime production and ability to form pigment solids determines infection severity and bacteremia |
| Q40011952 | Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis |
| Q33970448 | Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR |
| Q24792662 | Infection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosis |
| Q91908680 | Infections in cystic fibrosis |
| Q38752373 | Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota |
| Q34368544 | Interkingdom metabolic transformations captured by microbial imaging mass spectrometry |
| Q34284493 | Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms |
| Q55167938 | Iron at the Centre of Candida albicans Interactions. |
| Q41994275 | Killing of P. aeruginosa by chicken cathelicidin-2 is immunogenically silent, preventing lung inflammation in vivo |
| Q42038153 | Long Persistence of a Streptococcus pneumoniae 23F Clone in a Cystic Fibrosis Patient |
| Q37720396 | Medically important bacterial-fungal interactions |
| Q24533461 | Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia |
| Q36636914 | Microbiology of airway disease in patients with cystic fibrosis |
| Q37500602 | Pathogenesis of Fungal Infections in Cystic Fibrosis. |
| Q33859051 | Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. |
| Q44818432 | Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients |
| Q36965470 | Pseudomonas aeruginosa variants isolated from patients with cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes |
| Q43128362 | Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative |
| Q36732549 | Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. |
| Q64258896 | Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of |
| Q73912840 | Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis |
| Q43708818 | Selective pressure of antistaphylococcal chemotherapeutics in favour of Pseudomonas aeruginosa in cystic fibrosis |
| Q70363290 | Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa |
| Q68195534 | Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis |
| Q42625891 | Staphylococcus aureus in patients with cystic fibrosis: an epidemiological analysis using a combination of traditional and molecular methods |
| Q24802489 | State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? |
| Q37333372 | Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication |
| Q54257555 | Susceptibility to various antimicrobial agents ofStaphylococcus aureus isolates from cystic fibrosis patients |
| Q33825634 | The changing microbial epidemiology in cystic fibrosis |
| Q35987288 | The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications |
| Q40848578 | The innate immune system in cystic fibrosis lung disease |
| Q35191796 | The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans |
| Q34773499 | The role of inflammation in the pathophysiology of CF lung disease |
| Q43276198 | Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients |
| Q69471114 | Treatment of infections in patients with cystic fibrosis |
| Q42144395 | Truncation of type IV pilin induces mucoidy in Pseudomonas aeruginosa strain PAO579 |
| Q38714858 | Xanthomonas maltophilia: an emerging nosocomial pathogen |
| Q80941671 | [Aspergillus fumigatus and Candida albicans in cystic fibrosis: clinical significance and specific immune response involving serum immunoglobulins G, A, and M] |
Search more.